SAN FRANCISCO — Drugmaker AbbVie will “perform well” with whatever policy changes President-elect Trump makes, the company’s CEO said Wednesday morning.
Just minutes before AbbVie presented at the JPMorgan Healthcare Investor Conference, Trump gave a press conference in which he called for “new bidding procedures for the drug industry,” indicating he wants to crack down on drugmakers that price products expensively or raise the price of existing drugs.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.
